t2cure GmbH

t2cure GmbH (t2cure) is a pharmaceutical company engaged in the development of novel progenitor cell-based regenerative therapeutics. Its products are used in providing new treatment options to patients suffering from cardiac or peripheral vascular diseases like myocardial infarction or peripheral artery occlusive disease. The company also provides autologous bone marrow-derived progenitor cells as regenerative therapeutics. t2cure works in collaboration with some of the leading pharmaceutical companies such as INNOVECTIS GmbH, Hesseng GmbH and more in order to broaden its product portfolio by the effective usage of resources. The company is headquartered in Frankfurt am Main, Germany.

Street: 
Bettinastrabe 35-37
City: 
Frankfurt
Postcode: 
60325
Federal State : 
Germany
WebSite: 
www.t2cure.de
Fax: 
49-69-756146879

Company Index Score

Current Index Score Historical Index Score
  • t2cure GmbH currently scores 50 % in the index.
  • t2cure GmbH is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • t2cure GmbH is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets